Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Polymer from ethylenic monomers only
Patent
1977-09-19
1978-11-21
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Polymer from ethylenic monomers only
424 19, A61K 952, A61K 926
Patent
active
041266722
ABSTRACT:
Sustained release pharmaceutical capsules suitable for oral administration and particularly suitable for sustained release therapy with certain benzodiazepines, e.g. chlordiazepoxide and diazepam, are disclosed. The formulation contained in the disclosed capsules is hydrodynamically balanced to be buoyant in gastric fluid thereby remaining buoyant in the gastric fluid until substantially all of the medicament therein has been released.
REFERENCES:
patent: 3065143 (1962-11-01), Christenson et al.
patent: 3122474 (1964-02-01), Carstensen
patent: 3140978 (1964-07-01), Zentner
patent: 3365365 (1968-01-01), Butler et al.
patent: 3418999 (1968-12-01), Davis
patent: 3427378 (1969-02-01), Henderson et al.
patent: 3444290 (1969-05-01), Wai
patent: 3449489 (1969-06-01), Gaunt
patent: 3555151 (1971-01-01), Kaplan et al.
patent: 3574820 (1971-04-01), Johnson et al.
C.A. 60 #10484g(1964), 73 #69844c(1970), 76 #121938q(1972), 81 #54444p(1974).
Sheth Prabhakar R.
Tossounian Jacques L.
Hoffmann-La Roche Inc.
Leon Bernard S.
Rose Shep K.
Sax Jon S.
Swope R. Hain
LandOfFree
Sustained release pharmaceutical capsules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained release pharmaceutical capsules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release pharmaceutical capsules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2049557